APA

Squires M., Ward G., Saxty G., Berdini V., Cleasby A., King P., Angibaud P., Perera T., Fazal L., Ross D., Jones C. G., Madin A., Benning R. K., Vickerstaffe E., O'Brien A., Frederickson M., Reader M., Hamlett C., Batey M. A., Rich S., Carr M., Miller D., Feltell R., Thiru A., Bethell S., Devine L. A., Graham B. L., Pike A., Cosme J., Lewis E. J., Freyne E., Lyons J., Irving J., Murray C., Newell D. R. & Thompson N. T. (20120123). Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer models. : Molecular cancer therapeutics.

Chicago

Squires Matthew, Ward George, Saxty Gordan, Berdini Valerio, Cleasby Anne, King Peter, Angibaud Patrick, Perera Tim, Fazal Lynsey, Ross Douglas, Jones Charlotte Griffiths, Madin Andrew, Benning Rajdeep K, Vickerstaffe Emma, O'Brien Alistair, Frederickson Martyn, Reader Michael, Hamlett Christopher, Batey Michael A, Rich Sharna, Carr Maria, Miller Darcey, Feltell Ruth, Thiru Abarna, Bethell Susanne, Devine Lindsay A, Graham Brent L, Pike Andrew, Cosme Jose, Lewis Edward J, Freyne Eddy, Lyons John, Irving Julie, Murray Christopher, Newell David R and Thompson Neil T. 20120123. Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer models. : Molecular cancer therapeutics.

Harvard

Squires M., Ward G., Saxty G., Berdini V., Cleasby A., King P., Angibaud P., Perera T., Fazal L., Ross D., Jones C. G., Madin A., Benning R. K., Vickerstaffe E., O'Brien A., Frederickson M., Reader M., Hamlett C., Batey M. A., Rich S., Carr M., Miller D., Feltell R., Thiru A., Bethell S., Devine L. A., Graham B. L., Pike A., Cosme J., Lewis E. J., Freyne E., Lyons J., Irving J., Murray C., Newell D. R. and Thompson N. T. (20120123). Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer models. : Molecular cancer therapeutics.

MLA

Squires Matthew, Ward George, Saxty Gordan, Berdini Valerio, Cleasby Anne, King Peter, Angibaud Patrick, Perera Tim, Fazal Lynsey, Ross Douglas, Jones Charlotte Griffiths, Madin Andrew, Benning Rajdeep K, Vickerstaffe Emma, O'Brien Alistair, Frederickson Martyn, Reader Michael, Hamlett Christopher, Batey Michael A, Rich Sharna, Carr Maria, Miller Darcey, Feltell Ruth, Thiru Abarna, Bethell Susanne, Devine Lindsay A, Graham Brent L, Pike Andrew, Cosme Jose, Lewis Edward J, Freyne Eddy, Lyons John, Irving Julie, Murray Christopher, Newell David R and Thompson Neil T. Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer models. : Molecular cancer therapeutics. 20120123.